BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18162225)

  • 1. Oral and dental late effects after pediatric stem cell transplantation.
    Dahllöf G
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):81-3. PubMed ID: 18162225
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine complications of hematopoietic stem cell transplantation.
    Chemaitilly W; Sklar CA
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):983-98; ix. PubMed ID: 17983932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
    Bailey HK; Kappy MS; Giller RH; Gralla J
    Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late effects following hematopoietic cell transplantation for children.
    Dahllöf G; Hingorani SR; Sanders JE
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):88-93. PubMed ID: 18162227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
    Kal HB; van Kempen-Harteveld ML
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1525. PubMed ID: 18022583
    [No Abstract]   [Full Text] [Related]  

  • 6. Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation.
    ;
    Pediatr Dent; 2005-2006; 27(7 Suppl):170-5. PubMed ID: 16541917
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral Manifestations of Immunodeficiencies and Transplantation Medicine.
    Waring E; Villa A
    Atlas Oral Maxillofac Surg Clin North Am; 2017 Sep; 25(2):105-111. PubMed ID: 28778300
    [No Abstract]   [Full Text] [Related]  

  • 8. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late effects after autologous hematopoietic cell transplantation.
    Burns LJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):21-4. PubMed ID: 19147072
    [No Abstract]   [Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
    Cesaro S; Locatelli F; Lanino E; Porta F; Di Maio L; Messina C; Prete A; Ripaldi M; Maximova N; Giorgiani G; Rondelli R; Aricò M; Fagioli F
    Haematologica; 2008 Nov; 93(11):1694-701. PubMed ID: 18768529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent oral trimethoprim/sulfamethoxazole on two non-consecutive days per week is effective as Pneumocystis jiroveci pneumonia prophylaxis in pediatric patients receiving chemotherapy or hematopoietic stem cell transplantation.
    Ohata Y; Ohta H; Hashii Y; Tokimasa S; Ozono K; Hara J
    Pediatr Blood Cancer; 2009 Jan; 52(1):142-4. PubMed ID: 18819150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation.
    da Fonseca MA; Hong C
    Pediatr Dent; 2008; 30(2):98-104. PubMed ID: 18481573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation.
    American Academy of Pediatric Dentistry
    Pediatr Dent; 2004; 26(7 Suppl):144-9. PubMed ID: 15656454
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroblastoma, childhood cancer survivorship, and reducing the consequences of cure.
    Gurney JG
    Bone Marrow Transplant; 2007 Oct; 40(8):721-2. PubMed ID: 17912265
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia.
    Hunger SP; Loh KM; Baker KS; Schultz KR
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):79-83. PubMed ID: 19147083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male breast cancer 15 years after allogeneic hematopoietic cell transplantation including total body irradiation for recurrent acute lymphoblastic leukemia.
    Lowe T; Luu T; Shen J; Bhatia S; Shibata S; Stein A; Somlo G
    Onkologie; 2008 May; 31(5):266-9. PubMed ID: 18497517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline on dental management of pediatric patients receving chemotherapy, hematopoietic cell transplantation, and/or radiation.
    ;
    Pediatr Dent; 2008-2009; 30(7 Suppl):219-25. PubMed ID: 19216425
    [No Abstract]   [Full Text] [Related]  

  • 19. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BK virus encephalitis in an allogeneic hematopoietic stem cell recipient.
    Behre G; Becker M; Christopeit M
    Bone Marrow Transplant; 2008 Oct; 42(7):499. PubMed ID: 18622417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.